DAVID LIU,PAUL ANTHONY ESCARPE,ROBERT A. STULL,SCOTT J. DYLLA
申请号：
BR112017017927
公开号：
BR112017017927A2
申请日:
2016.02.23
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The present invention relates to chimeric anti-dll3 antigen receptors and methods of using them to treat proliferative disorders.a presente invenção refere-se a receptores quiméricos de antígenos anti-dll3 e a métodos de uso dos mesmos para tratar distúrbios proliferativos.
